Assessment of an Oral Endotracheal Subglottic Tube Holder
Assessment of AnchorFast Guard Subglottic ET (Endotracheal) Tube
1 other identifier
interventional
34
1 country
4
Brief Summary
This study is designed to assess the acceptability and usability of a new Endotracheal Tube (ET) holding device for an orally intubated patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2017
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2017
CompletedStudy Start
First participant enrolled
October 23, 2017
CompletedFirst Posted
Study publicly available on registry
November 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2018
CompletedResults Posted
Study results publicly available
July 5, 2019
CompletedJuly 5, 2019
April 1, 2019
8 months
October 16, 2017
April 11, 2019
July 2, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Overall Acceptability With Study Product
The overall acceptability relating to general experience with the study product during use will be rated with a 5-point Likert scale ranging from 1=Very Unacceptable to 5=Very Acceptable
At product removal (maximum 29 days of patient wearing product)
Usability of Study Product
The usability of the study product at application and at removal.
At application and product removal (maximum 29 days of patient wearing product)
Study Arms (1)
New oral endotracheal tube holder
EXPERIMENTALSingle Study Product Arm
Interventions
The single arm study product is designed to hold a standard or subglottic ET tube.
Eligibility Criteria
You may qualify if:
- Is 18 years of age or older and require oral tracheal intubation with subglottic ET tube size 6.0-8.0mm
- Requires the use of a bite block per the hospital's standard of care
- Has intact skin on and around application site, including cheeks and lips
- Oral cavity is free of open sores, ulcers, wounds, and lesions
- Subject or Legal Authorized representative (LAR) able to provide informed consent for the study
- Is qualified to participate in the opinion of the Investigator, or designee
You may not qualify if:
- Has actual or perceived loose teeth, is without teeth, or is unable to wear upper dentures
- Has facial hair that interferes with the adhesion of the skin barrier pads
- Has a clinically significant skin disease or condition, or damaged skin on the application site, such as psoriasis, eczema, atopic dermatitis, active cancer, sores, sunburns, scars, moles
- Has a medical condition, surgery or a procedure that prevents the proper application of the device, including placement of the neck strap.
- Has a known or stated allergy to adhesives
- Currently is participating in any clinical study which may affect the performance of the device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Community Regional Medical Center
Fresno, California, 93701, United States
Legacy Mount Hood Medical Center
Gresham, Oregon, 97030, United States
Legacy Good Samaritan Medical Center
Portland, Oregon, 97210, United States
Legacy Emanuel Hospital & Health Center
Portland, Oregon, 97227, United States
Related Publications (2)
Buckley JC, Brown AP, Shin JS, Rogers KM, Hoftman NN. A Comparison of the Haider Tube-Guard(R) Endotracheal Tube Holder Versus Adhesive Tape to Determine if This Novel Device Can Reduce Endotracheal Tube Movement and Prevent Unplanned Extubation. Anesth Analg. 2016 May;122(5):1439-43. doi: 10.1213/ANE.0000000000001222.
PMID: 26983051BACKGROUNDMohammed, H & Hassan, M. (2015). Endotracheal tube securements: Effectiveness of three techniques among orally intubated patients. Egyptian Journal of Chest Diseases and Tuberculosis 64:183-196
BACKGROUND
Results Point of Contact
- Title
- Director Global Clinical Affairs
- Organization
- Hollister Incorporated
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Vander Werff, MD
Legacy Mount Hood Medical Center
- PRINCIPAL INVESTIGATOR
Brian Young, MD
1. Legacy Emanuel Hospital & Health Center 2. Legacy Good Samaritan Medical Center
- PRINCIPAL INVESTIGATOR
Arash Afshinnik, MD
Community Regional Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2017
First Posted
November 1, 2017
Study Start
October 23, 2017
Primary Completion
June 8, 2018
Study Completion
June 15, 2018
Last Updated
July 5, 2019
Results First Posted
July 5, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share